moderna covid - Search News

News

Moderna to cut 10% of global workforce

Reuters on MSN · 1d

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by robust Spring COVID booster demand and aggressive cost cuts. However, its shares fell more than 4% in premarket trading after the company lowered its 2025 sales forecast to $1.

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Fox Business on MSN · 1d

Moderna plans to slash 10% of workforce as COVID shot sales slow

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.

Moderna will lay off about 500 workers

CBS News on MSN · 1d

Moderna will lay off 10% of employees, Massachusetts-based company announces

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, announced Thursday that it will lay off about 10% of its workforce.

WCVB Channel 5 Boston · 1d

Cambridge-based Moderna announces plan to cut workforce by 10%

The Cambridge-based vaccine maker, which became a household name during the pandemic, is cutting its global workforce to under 5,000 employees.

Moderna will lay off about 500 workers as part of cost-cutting plan

In a statement on Thursday sharing the news, Moderna CEO Stéphane Bancel called the layoffs “a difficult decision but [a] necessary step forward.” “This decision was not made lightly,” Bancel continued.

2don MSN

Moderna to Cut 10% of Staff to Offset Slowing Covid Business

Moderna Inc. is cutting about 10% of its workforce, part of an effort by the struggling biotech company to reduce spending as ...

1d

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Fierce Pharma22h

Despite ongoing decline, Moderna's Spikevax sales beat expectations in Q2

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which ...

21h

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

20hon MSN

Moderna cuts sales forecast on UK revenue delay, shares fall

Moderna trimmed its 2025 revenue forecast on Friday after UK deliveries of some COVID vaccines were deferred to next year, ...

1d

Moderna falls as cost-cutting fails to appease investors

Moderna Inc. shares declined as the company’s cost-cutting efforts failed to assuage investors who are worried about the ...

3hon MSN

Will health insurance pay for Covid vaccines this fall?

HHS Secretary Robert F. Kennedy Jr. has upended the way Covid vaccines are approved and for whom they’re recommended, ...

20hon MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results